Help | RSS Feed

Cryo-Cell Intl, Inc. (OTCMKT:CCEL) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Cryo-Cell Intl, Inc. (OTCMKT:CCEL) seasonal charts above shows that a Buy Date of April 2 and a Sell Date of July 2 has resulted in a geometric average return of 17.06% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 18 of those periods. This is an excellent rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 18.82% per year.

The seasonal timeframe is Inline with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. It organized in three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of Prepacyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment which consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. All the business activity of the group is functioned through the United States and it derives revenue from processing and testing fees and storage fees charged each year for storage and through sales of the Prepacyte CB units.

To download CCEL seasonal chart data, please log in or Subscribe.


Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z